Table 2 Secondary analysis of three longitudinal studies reporting distress prevalence in the follow-up period
| Â | Â | Â | Â | Â | Â | Â | Baseline | Follow-up | Comparison | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
First author | Year | Country | Study design | When distress assessed initially | Distress cut-off | Follow-up | No. of patients with Distress, n | Total number of Patients assessed, n | Prevalence of Distress,%(95% Cl) | No. of patients with Distress, n | Total number of Patients assessed, n | Prevalence of Distress,%(95% Cl) | Relative Increase Ratio,%(95% Cl) |
Rooney | 2012 | UK | longitudinal | during primary radiotherapy | DT ≥ 4 | 3 mo | 19 | 155 | 12.3 (7.1–17.4) | 15 | 108 | 13.9 (7.4–20.4) | 0.81 (0.42,1.54) |
Trad | 2015 | Australia | longitudinal | newly diagnosis or first recurrence | DT ≥ 4 | 3 mo | 36 | 96 | 37.5 (27.8–47.2) | 9 | 12 | 75.0 (50.5–99.5) | 1.57 (0.89,2.77) |
Rooney | 2013 | UK | longitudinal | shortly after starting chemo/radiotherapy | DT ≥ 4 | 3 mo | 56 | 154 | 36.4 (28.8–44.0) | 37 | 103 | 35.9 (26.7–45.2) | 0.99 (0.78,1.35) |